secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outlook Therapeutics, Inc. (OTLK)
CIK:        0001649989
Form:       8-K
Filed at:   2024-03-18T23:59:59+00:00
Accession:  0001104659-24-035644
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outlook Therapeutics closes $60M private placement and effects 1-for-20 reverse stock split
--------------------------------------------------------------------------------

- Private placement raised ~$60M via 8.57M shares at $7.00 each plus warrants for 12.86M shares at $7.70.
- Warrants expire March 18, 2029; exercise price $7.70 per share.
- 1-for-20 reverse stock split effective March 13, 2024; authorized shares reduced to 60M.
- After split and before placement, ~13.0M shares outstanding; securities sold under Rule 506 exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649989/000110465924035644/0001104659-24-035644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649989/000110465924035644/tm249047d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-035644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer